Cochrane Urology is dedicated to drafting systematic reviews of the best available evidence from randomized controlled trials (when available) and nonrandomized controlled clinical trials of interventions related to the diagnosis, prevention, treatment, and rehabilitation of
- Benign and malignant prostate conditions, including benign prostatic hyperplasia, prostate cancer, and prostatitis;
- Male sexual dysfunction, including erectile dysfunction, undescended testes, and Peyronie's disease;
- Benign and malignant renal conditions, including cancer and stones; and
- Urologic cancers, including bladder, testicular, penile, and urethral.
The topic of incontinence is handled by the Cochrane Incontinence Group.